Heart Failure Management in a Changing Paradigm
Published: 27 June 2022
For this unique broadcast, Radcliffe Medical Education bring together a globally-renowned European and American faculty to participate in a roundtable discussion. Radcliffe’s roundtable discussions provide reflection on recently published data and examine what future developments can be expected at forthcoming events, through lively discussion and data presentations.
Prof Andrew Coats (University of Warwick, UK) leads proceedings, and is joined by Dr Shelley Zieroth (University of Manitoba, CA), Dr Javed Butler (University of Mississippi Medical Center, Jackson, MS) and Dr Piotr Ponikowski (Wroclaw Medical University, Wroclaw, PL) for an insightful presentation and a discussion.
- Recall the utility of EF in heart failure treatment, patient selection and treatment response
- Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
- Incorporate quality of life measures for assessing therapeutic efficacy in HF
- Recall outcomes from heart failure trials from recent congress and publications and their impact on practice
Ejection Fraction in Context
Life beyond Ejection Fraction
New data in HF and how to apply them to practice
Roundtable Discussion: HF management in a changing paradigm
University of Manitoba, Canada
Dr Shelley Zieroth is at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada.
Dr Zieroth attended medical school at the University of Manitoba, where she went on to train in internal medicine and cardiology. She completed her postdoctoral clinical fellowship, specializing in advanced heart failure and cardiac transplant, at Toronto General Hospital. Dr Zieroth has lectured internationally on the subject of heart failure.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
Professor of Medicine
Dr Javed Butler is President, Baylor Scott and White Research Institute, Dallas, TX and Professor of Medicine, University of Mississippi, Jackson, MS, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He has authored more than 900 peer-reviewed publications.
Andrew JS Coats
Director of the Monash Warwick Alliance and Academic Vice-President
Prof Andrew Coats is President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK. He is an Australian-British academic cardiologist and inventor. Prof Coats' main interest is heart failure.
From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine of the University of Sydney.
He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor.
Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board.
Head of the Department of Heart Diseases
Piotr Ponikowski is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical rehabilitation in patients with chronic HF, assessment of metabolic derangements in HF (with special interest in iron deficiency), evaluation of reflex control in the cardiorespiratory system in order to optimise assessment and management of patients with HF. He has been involved in numerous clinical trials as main investigator, member of international steering committees, endpoint committees and advisory boards.